Cover Image

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome

Saved in:

Bibliographic Details
Main Authors:	Ilana D. Breen, BS (Author), Caitlin M. Brumfiel, MS (Author), Meera H. Patel, BS (Author), Allison C. Rosenthal, DO (Author), William G. Rule, MD (Author), David J. DiCaudo, MD (Author), Fiona E. Craig, MD (Author), Mark R. Pittelkow, MD (Author), Aaron R. Mangold, MD (Author)
Format:	Book
Published:	Elsevier, 2021-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dupilumab as a therapy option for treatment refractory mogamulizumab-associated rash
by: Nicholas A. Trum, BS, et al.
Published: (2021)

Thymoma-associated multiorgan autoimmunity treated with multimodal therapy including extracorporeal photopheresis
by: Chikoti M. Wheat, MD, et al.
Published: (2021)

Sézary Syndrome with Nodal CD30-positive Manifestation Treated with Brentuximab Vedotin and Extracorporeal Photopheresis
by: Valeria Behle, et al.
Published: (2017)

Sustained Complete Remission in Sézary Syndrome using Extracorporeal Photopheresis: A Multicentric Case Series
by: Rohat Cankaya, et al.
Published: (2024)

Primary cutaneous epidermotropic marginal zone B-cell lymphoma treated with total skin electron beam therapy
by: Blake W. Boudreaux, MD, et al.
Published: (2021)

Alopecia areata after mogamulizumab treatment
by: Neel S. Raval, BS, MPHS, et al.
Published: (2022)

Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
by: Carine M. Lama, MS, et al.
Published: (2023)

A case of B-cell lymphoblastic leukemia cutis flaring following CAR T-cell therapy in a patient with refractory acute lymphoblastic leukemia
by: Pranav Puri, BA, et al.
Published: (2021)

Alemtuzumab as initial therapy for Sézary syndrome: A report of 2 cases
by: Caitlin M. Brumfiel, MS, et al.
Published: (2020)

Alopecia areata-like presentations with mogamulizumab therapy
by: Colin M. Kincaid, BS, et al.
Published: (2023)

Abscopal Effect After Localized Radiotherapy in a Patient With Sezary Syndrome Under Treatment with Mogamulizumab
by: Vieri Grandi, et al.
Published: (2023)

Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sezary syndrome cutaneous T-cell lymphoma
by: Noemi Muszbek, et al.
Published: (2023)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021)

Primary cutaneous diffuse large B-cell lymphoma, leg type, presenting as subcutaneous nodules: Case series and comparison of treatment outcomes
by: Jake G. Besch, MD, et al.
Published: (2023)

A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome
by: Andjela Egger, BS, et al.
Published: (2020)

Systemic sclerosis with morphea-like plaques histopathologically mimicking cutaneous B-cell lymphoma
by: Ana M. Aragon Sierra, BS, et al.
Published: (2024)

Safety and Efficacy of Extracorporeal Photopheresis for Acute and Chronic Graft-versus-Host Disease
by: Eleni Gavriilaki, et al.
Published: (2024)

Ulceronecrotic rash in an immunocompetent individual
by: Shae Margulies, BS, et al.
Published: (2022)

Facial rash with exuberant crusting in pregnancy
by: Raymond Zhao, BS, et al.
Published: (2022)

Paraneoplastic morphea with prominent mucin deposition
by: Ahmad B. Shahin, BS, et al.
Published: (2023)

Induction of remission in a patient with end-stage cutaneous T-cell lymphoma by concurrent use of radiation therapy, gentian violet, and mogamulizumab
by: Sarah A. Westergaard, MD, et al.
Published: (2020)

Acute progression of the leukemic phase in mycosis fungoides and Sézary syndrome
by: Hasina Maredia, MD, et al.
Published: (2021)

Diffuse blistering rash with ocular involvement
by: Shae Margulies, BS, et al.
Published: (2022)

A painful rash on a white woman
by: Grace O'Neill, BS, et al.
Published: (2020)

Recalcitrant facial rash: Cutaneous coccidioidomycosis
by: Shanice A. McKenzie, BS, et al.
Published: (2020)

A rapidly fluctuating rash in a stuporous patient
by: Nelson Ugwu, BS, et al.
Published: (2021)

Effective treatment of mogamulizumab-induced head and neck dermatitis with fluconazole in a patient with peripheral E-cell lymphoma
by: Ishan Asokan, MD, MSc, et al.
Published: (2022)

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
by: Inga Hansen, et al.
Published: (2024)

Sezary syndrome initially presenting as pityriasis rubra pilaris: Clinicopathologic study of 3 cases
by: Mouaz Alsawas, MD, MSc, et al.
Published: (2024)

Efficacy of rituximab in pediatric pemphigus: A literature review
by: Meera H. Patel, BS, et al.
Published: (2022)

Sezary syndrome, thyroid carcinoma, and renal carcinoma in a patient with Poland syndrome
by: Alexandra Kuzyk, MD, PhD, et al.
Published: (2022)

Dermoscopic Description of Fibroepithelioma of Pinkus with Negative Network
by: Yousif Yonan, et al.
Published: (2019)

Drug rash with eosinophilia and systemic symptoms related to brentuximab vedotin: A report of 2 cases
by: Laura Ragmanauskaite, MD, et al.
Published: (2020)

Hemorrhagic rash on the legs
by: Stephan Traidl, MD, et al.
Published: (2021)

Sézary syndrome associated vitiligo-like leukoderma in type V skin: Report of a case and review of the literature
by: Fatima N. Mirza, MD, MPH, et al.
Published: (2024)

Partial remission of advanced untreated Sézary syndrome after COVID-19
by: Caroline Snowden, BA, et al.
Published: (2022)

Double-positive CD4 and CD8 Sézary syndrome
by: Denis Miyashiro, MD, et al.
Published: (2017)

A red-orange rash in a patient with skin of color
by: Ista A. Egbeto, BS, et al.
Published: (2021)

Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma
by: Caitlin M. Brumfiel, MS, et al.
Published: (2021)

Two infants with blistering rashes originating on acral sites as a presenting sign of infantile bullous pemphigoid
by: Brent Folsom, BS, et al.
Published: (2020)